WANY
TECH icon

Wealthspire Advisors (New York)’s Bio-Techne TECH Stock Holding History

Wealthspire Advisors (New York)’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-72
Closed -$4.01K – 2703
2025
Q3 		$4.01K Buy
+72
New +$3.86K ﹤0.01% 2407
2021
Q2 		– Sell
-2,276
Closed -$217K – 631
2021
Q1 		$217K Buy
+2,276
New +$208K 0.01% 652

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wealthspire Advisors (New York)'s TECH Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 72 shares — an estimated $4.01K sold.

Wealthspire Advisors (New York) first reported a position in TECH in Q1 2021 and held it in 2 quarters. The position peaked at $217K in Q1 2021. 585 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 72 Bio-Techne shares in Q4 2025, an estimated $4.01K.
  • Wealthspire Advisors (New York) first reported a position in Bio-Techne in Q1 2021 and held it in 2 quarters.
  • Wealthspire Advisors (New York)'s Bio-Techne position peaked at $217K in Q1 2021.
  • 585 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.